Haas L,
Cruz-Pamplona M. Topical treatment of oral chronic graft-versus-host- disease
in hematopoietic stem cell transplant recipients: A systematic review. J Clin
Exp Dent. 2023;15(5):e420-7.
doi:10.4317/jced.60138
https://doi.org/10.4317/jced.60138
__________
References
|
1.
Zakrzewski W, Dobrzyński M, Szymonowicz M, Rybak Z. Stem cells: past,
present, and future. Stem Cell Research & Therapy. 2019;10:68. |
|
|
|
|
|
2.
Bazinet A, Popradi G. A general practitioner's guide to hematopoietic
stem-cell transplantation. Current Oncology. 2019;26:187-91. |
|
|
|
|
|
3.
Alexander T, Greco R, Snowden JA. Hematopoietic Stem Cell Transplantation for
Autoimmune Disease. Annu Rev Med. 2021;72:215-28. |
|
|
|
|
|
4.
Sureda A, Bader P, Cesaro S, Dreger P, Duarte RF, Dufour C, et al.
Indications for allo- and auto-SCT for haematological diseases, solid tumours
and immune disorders: Current practice in Europe, 2015. Bone Marrow Transplantation.
2015;50:1037-56. |
|
|
|
|
|
5.
Moreno DF, Cid J. Enfermedad del injerto contra el receptor. Med Clin (Barc).
2019;152:22-8. |
|
|
|
|
|
6.
Gyurkocza B, Sandmaier BM. Conditioning regimens for hematopoietic cell
transplantation: One size does not fit all. Blood. 2014;124:344-53. |
|
|
|
|
|
7.
Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, et al. Guidelines
for Preventing Infectious Complications among Hematopoietic Cell
Transplantation Recipients: A Global Perspective. Biol Blood Marrow
Transplant. 2009;15:1143-238. |
|
|
|
|
|
8.
Ramachandran V, Kolli SS, Strowd LC. Review of Graft-Versus-Host Disease.
Dermatol Clin. 2019;37:569-82. |
|
|
|
|
|
9.
Fall-Dickson JM, Pavletic SZ, Mays JW, Schubert MM. Oral Complications of
Chronic Graft-Versus-Host Disease. J Natl Cancer Inst Monogr. 2019;2019:lgz007. |
|
|
|
|
|
10.
Kuten-Shorrer M, Woo S bin, Treister NS. Oral Graft-Versus-Host Disease. Dent
Clin North Am. 2014;58:351-68. |
|
|
|
|
|
11.
Arora M. Therapy of chronic graft-versus-host disease. Best Pract Res Clin
Haematol. 2008;21:271-9. |
|
|
|
|
|
12.
Elad S, Aljitawi O, Zadik Y. Oral Graft-Versus-Host Disease: A Pictorial
Review and a Guide for Dental Practitioners. Int Dent J. 2021;71:9-20. |
|
|
|
|
|
13.
Granitto MH arvey, Fall-Dickson JM, Norton CK, Sanders C. Review of therapies
for the treatment of oral chronic graft-versus-host disease. Clin J Oncol
Nurs. 2014;18:76-81. |
|
|
|
|
|
14.
del Fante C, Perotti C, Bonferoni MC, Rossi S, Sandri G, Ferrari F, et al.
Platelet lysate mucohadesive formulation to treat oral mucositis in graft
versus host disease patients: A new therapeutic approach. AAPS PharmSciTech.
2011;12:893-9. |
|
|
|
|
|
15.
Bojanic I, Mravak Stipetic M, Pulanic D, Desnica L, Mazic S, Golubic Cepulic
B, et al. Autologous blood as a source of platelet gel for the effective and
safe treatment of oral chronic graft-versus-host disease. Transfusion
(Paris). 2018;58:1494-9. |
|
|
|
|
|
16.
Mawardi H, Stevenson K, Gokani B, Soiffer R, Treister N. Combined topical
dexamethasone/tacrolimus therapy for management of oral chronic GVHD. Bone
Marrow Transplant. 2010;45:1062-7. |
|
|
|
|
|
17.
Elad S, Garfunkel A, Enk C, Galili D, Or R. Ultraviolet B irradiation: a new
therapeutic concept for the management of oral manifestations of
graft-versus-host disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
1999;88:444-50. |
|
|
|
|
|
18.
Epstein JB, Raber-Durlacher JE, Epstein GL, Hazenberg MD, Tzachanis D,
Spielberger RT. Chronic oral graft-versus-host disease: induction and
maintenance therapy with photobiomodulation therapy. Support Care Cancer.
2021;29:1387-94. |
|
|
|
|
|
19.
Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al.
PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for
reporting systematic reviews. The BMJ. 2021;372:n160. |
|
|
|
|
|
20.
Oxford: CASP UK. CASP Critical Appraisal Skills Programme [Internet]. 2020
[cited 2022 Mar 24]. Available from: https://casp-uk.net/ |
|
|
|
|
|
21.
Noce CW, Gomes A, Shcaira V, Corrêa ME, Moreira MC, Silva Júnior A, et al.
Randomized double-blind clinical trial comparing clobetasol and dexamethasone
for the topical treatment of symptomatic oral chronic graft-versus-host
disease. Biol Blood Marrow Transplant. 2014;20:1163-1168. |
|
|
|
|
|
22.
Bardellini E, Amadori F, Conti G, Veneri F, Majorana A. Effectiveness of a
spray containing 1% malic acid in patients with xerostomia induced by
graft-versus-host disease. Med Oral Patol Oral Cir Bucal. 2019;24:e190-4. |
|
|
|
|
|
23.
Elad S, Zeevi I, Finke J, Koldehoff M, Schwerdtfeger R, Wolff D, et al.
Improvement in Oral Chronic Graft-versus-Host Disease with the Administration
of Effervescent Tablets of Topical Budesonide-An Open, Randomized,
Multicenter Study. Biol Blood Marrow Transplant. 2012;18:134-40. |
|
|
|
|
|
24.
Treister N, Li S, Kim H, Lerman M, Sultan A, Alyea EP, et al. An Open-Label
Phase II Randomized Trial of Topical Dexamethasone and Tacrolimus Solutions
for the Treatment of Oral Chronic Graft-versus-Host Disease. Biol Blood
Marrow Transplant. 2016;22:2084-2091. |
|
|
|
|
|
25.
Mansourian A, Bahar B, Moosavi MS, Amanlou M, Babaeifard S, Babaeifard S.
Comparison of the Efficacy of Topical Triamcinolone in Orabase and Curcumin
in Orabase in Oral Graft-Versus-Host Disease. J Dent (Tehran). 2017;14:313-20. PMid:29942325
PMCid:PMC6015590 |
|
|
|
|
|
26.
Albuquerque R, Khan Z, Poveda A, Higham J, Richards A, Monteiro L, et al.
Management of oral graft versus host disease with topical agents: A
systematic review. Med Oral Patol Oral Cir Bucal. 2016;21:e72-81. |
|
|
|
|
|
27.
Elsaadany BA, Ahmed EM, Aghbary SMH. Efficacy and Safety of Topical
Corticosteroids for Management of Oral Chronic Graft versus Host Disease. Int
J Dent. 2017;2017:1908768. |
|
|
|
|
|
28.
Sava A, Piciu A, Pasca S, Mester A, Tomuleasa C. Topical Corticosteroids a
Viable Solution for Oral Graft Versus Host Disease? A Systematic Insight on
Randomized Clinical Trials. Medicina (Kaunas). 2020;56:349. |
|
|
|
|
|
29.
Gambon DL, Brand HS, Nieuw Amerongen A v. The erosive potential of candy
sprays. Br Dent J. 2009;206:E20. |
|
|
|
|
|
30.
da Mata ADSP, Marques DNDS, Silveira JML, Marques JROF, Felino ETDMC,
Guilherme NFRPM. Effects of gustatory stimulants of salivary secretion on
salivary pH and flow: A randomized controlled trial. Oral Dis. 2009;15:220-8. |
|
|
|
|
|
31.
Gonzalez-Moles MA, Ruiz-Avila I, Rodriguez-Archilla A, Morales-Garcia P,
Mesa-Aguado F, Bascones-Martinez A, et al. Treatment of severe erosive
gingival lesions by topical application of clobetasol propionate in custom
trays. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:688-92. |
|
|
|
|
|
32.
Jajarm HH, Falaki F, Mahdavi O. A comparative pilot study of low intensity
laser versus topical corticosteroids in the treatment of erosive-atrophic
oral lichen planus. Photomed Laser Surg. 2011;29:421-5. |
|
|
|
|
|
33.
Wolff D, Anders V, Corio R, Horn T, Morison WL, Farmer E, et al. Oral PUVA
and topical steroids for treatment of oral manifestations of chronic
graft-vs.-host disease. Photodermatol Photoimmunol Photomed. 2004;20:184-90. |
|
|
|
|
|
34.
Kuhad A, Pilkhwal S, Sharma S, Tirkey N, Chopra K. Effect of curcumin on
inflammation and oxidative stress in cisplatin-induced experimental
nephrotoxicity. J Agric Food Chem. 2007;55:10150-5. |
|
|
|
|
|
35.
Lin MT, Storer B, Martin PJ, Tseng LH, Gooley T, Chen PJ, et al. Relation of
an Interleukin-10 Promoter Polymorphism to Graft-versus-Host Disease and
Survival after Hematopoietic-Cell Transplantation. N Engl J Med. 2003;23:2201-10. |
|
|
|
|
|
36.
Shahrabi Farahani S, Treister NS, Khan Z, Woo S. Oral Verruciform Xanthoma
Associated with Chronic Graft-Versus- Host Disease: A Report of Five Cases
and a Review of the Literature. Head Neck Pathol. 2011;5:193-8. |
|